UPC Case Law
Alexion Pharmaceuticals, Inc. v Amgen Technology (Ireland) Unlimited Company and others
Order of the UPC Court of Appeal of 20 December 2024, UPC CoA 405/2024
UPC Case Law by Pitch, edited by Bart Lieben · Published
TL;DR
The Court of Appeal rejected Alexion's appeal, so no provisional measures will be ordered against Amgen's eculizumab biosimilar BEKEMV®. Claim 2 of EP 3167888 had to be read literally, including 22 extra amino acids that Alexion said were an obvious error, and on that reading the claim is more likely than not insufficiently disclosed. The order sets a strict test for correcting errors in a claim by interpretation and confirms that statements made during grant can show how the skilled person reads the claim.
Key holding
A linguistic error, spelling mistake or other inaccuracy in a patent claim can only be corrected by interpretation if both the existence of the error and the precise way to correct it are sufficiently certain to the average skilled person. That certainty must come from the claim, read with the description and drawings and using common general knowledge. The patentee's assertions during grant proceedings, and especially a Technical Board of Appeal's endorsement of them, can indicate how the skilled person understood the claim at the filing date.
Questions decided
- When can an error in a patent claim be corrected by way of claim interpretation?
- Can statements made by the applicant during EPO grant proceedings inform claim interpretation?
- Does a merely statistical prediction of a signal-peptide cleavage site make a correction sufficiently certain?
- Is validity sufficiently certain for provisional measures where the claim as properly read is likely insufficiently disclosed under Art 83 EPC?
Full summary
Read the full analyses for free — create a free account
With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.
In the same case
More on provisional measures
- Decision · UPC CoA 49/2026
Guardant Health, Inc. v Sophia Genetics SA and others
The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- Order · UPC CoA 61/2026
SharkNinja Operating LLC v Groupe SEB France and others
The Court of Appeal overturned the Paris Local Division and granted SharkNinja a provisional injunction in France and Germany against SEB's "Cookeo Infinity" multicookers.
- Order · UPC CoA 936/2025
Amazon.com, Inc. and others v InterDigital VC Holdings, Inc. and others
The Court of Appeal permitted InterDigital to withdraw its application for provisional measures against Amazon while Amazon's appeal was pending, and declared the proceedings closed.
- Order · UPC CoA 108/2026
AIM Sport Development AG v TGI Sport Suomi Oy and others
The Court of Appeal's judge-rapporteur held that an appeal against a first-instance order disposing of an application for provisional measures is an appeal against a final decision under R 220.1(a) RoP, because R 363.2 RoP gives such orders that status.
- Order · UPC CoA 36/2026
Angelalign Technology Inc. and others v Align Technology, Inc.
The Court of Appeal rejected Angelalign's appeal and upheld the Düsseldorf preliminary injunction against the "Live Now" feature of its iOrtho orthodontic planning software.